Caribou says partial HLA matching will improve durability of response to cell therapy

CHICAGO — Caribou’s off-the-shelf cell therapy appears poised to break free from the rapid relapses that have plagued other off-the-shelf cell therapies, according to a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

New mechanism discovered: B cells’ contribution to immune tolerance in thymus gland

Immune cells must learn not to attack the body itself. A team of researchers from the Technical University of Munich (TUM) and the Ludwig Maximilian

February 21, 2024

J&J subsidiary gains approval for heart ablation devices to use without fluoroscopy

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson & Johnson subsidiary Biosense

August 7, 2023

Multidrug-resistant E.coli outcompete harmless strains to take over the gut, study reveals

Different strains of E.coli can outcompete one another to take over the gut, a new study reveals.

October 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.